Program Information

2015 Schedule 

Designed to blend the latest advancements in science with practical clinical approaches to patient management, PCNA’s Annual Symposium features keynote addresses, lectures and workshops presented by world-renowned authorities in cardiovascular risk reduction and disease management. New this year: Pharmacology Preconference made specifically for Advance Practice Nurses in cardiology. Pre-course work and post-course evaluation required; earn 7 hours of pharmacology credit. 

Wednesday, April 8           Pharmacology Preconference

*Pharmacology Preconference may be attended as a stand-alone event                                   

11:00 a.m. - 12:15 p.m.   Lunch Product Theater (non-CE)

Cholesterol Management
hosted by Kowa
     
12:30 p.m. - 12:45 p.m.   Welcome

Course Director, Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA

     
12:45 p.m. - 2:15 p.m.  

Antihyperglycemic Agents in the Treatment of Patients with Type 2 Diabetes 
Cindy Lamendola, MSN, ANP-BC, FAHA, FPCNA

     
 2:30 p.m. - 3:45 p.m.  

CVD Risk Reduction with Lipid-Lowering Medications: Statins and Beyond
Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN

     
3:45 p.m. - 5:00 p.m.   Pharmacotherapy for the Management of Heart Failure

Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA



5:00 p.m. - 5:30 p.m.   Case Studies with All Faculty Panel

Thursday, April 9       Annual Symposium

 8:15 a.m.   Breakfast
     
8:30 a.m. - 9:15 a.m.  

Welcome, Awards, Annual Review, President's Address

     
9:15 a.m. - 10:15 a.m.  

Venous Thromboembolism (VTE)
Speaker TBD

     
10:25 a.m. - 11:20 a.m.  

Exercise Really IS Medicine
Robert Sallis, MD

     
11:20 a.m. - 12:10 p.m.
 

Heart Health and Brain Health: Same Formula?
Neelum Aggarwal, MD

     
 12:20 p.m. - 2:05 p.m.   Exhibits
     
 12:20 p.m. - 1:15 p.m.   Lunch Product Theater (non-CE)

Speak from the Heart/Angina
hosted by Gilead
     
12:30 p.m.  

Leadership Luncheon (Invitation Only)

     
2:10 p.m. - 3:00 p.m.  

Race and Ethnicity: Impact on Heart Disease
Clyde Yancy, MD, MSc, FACC, FAHA, MACP

     
 3:05 p.m. - 4:00 p.m.    Repeated concurrent sessions - Choose One

 

 

  Beyond Scare Tactics: Effective Risk Communication Strategies

Lola A. Coke, PhD, ACNS-BC, RN-BC, FAHA, FPCNA

Exercise is Heart Failure Medicine Too

Nancy Houston Miller, RN, BSN, FAHA, FPCNA

Management of Pregnancy in Women with Heart Disease

Mary Canobbio, MN, RN, FAAN


Moderated Poster Session I
     
4:05 p.m. - 5:00 p.m.    Repeated concurrent sessions - Choose One
     
    Beyond Scare Tactics: Effective Risk Communication Strategies

Lola A. Coke, PhD, ACNS-BC, RN-BC, FAHA, FPCNA

Exercise is Heart Failure Medicine Too

Nancy Houston Miller, RN, BSN, FAHA, FPCNA

Management of Pregnancy in Women with Heart Disease

Mary Cannobbio, MN, RN, FAAN

Moderated Poster Session II
     
5:00 p.m. - 6:30 p.m.   Exhibits, Opening Reception, and Poster Presentations

 
 6:45 p.m. - 7:45 p.m.   Product Theater Dinner (non-CE)

AFib and Stroke Prevention
hosted by Janssen Pharmaceuticals
     

Friday, April 10

 8:15 a.m.   Breakfast
     
8:30 a.m. - 8:45 a.m.  

Welcome: Fellow Recognition, Poster Winners Announced

     
8:45 a.m. - 9:45 a.m.   Acute Coronary Syndrome (ACS)

Speaker TBD

     
9:45 a.m. - 10:45 a.m.  

Break / Exhibits Open

     
10:45 a.m. - 11:15 a.m.  

Winning Abstract Presentations 

     
11:20 a.m. - 12:15 p.m.  

What's a Clinician to do? Implementation of the 2013 Prevention Guidelines
Donald Lloyd Jones, MD, ScM, FACC, FAHA

     
12:20 p.m. - 2:15 p.m.    Exhibits 
     
12:20 p.m. - 1:30 p.m.   Product Theater Lunch (non-CE)

Triglycerides
hosted by AstraZeneca
     
2:15 p.m. - 3:05 p.m.  

Beyond Statins: What Does the Future of Dyslipidemia Treatment Hold?
Karol Watson, MD, PhD

     
 3:15 p.m. - 4:10 p.m.   Repeated concurrent sessions - Choose one
     

 

  What Can We Offer the Patient with Resistant Hypertension in 2015?

Joel Handler, MD
 

Safe Transition from H2H

Kim Newlin, RN, CNS, NP-C, FPCNA

Surgical Approaches to Obesity: Long Term Impact on CV Risk

John Morton, MD, MPH, FACS, FASMBS


Cardiac Device Update: New Tools and New Indications

Robin Trupp, PhD, ACNP-BC, CHFN, FAHA

     
4:15 p.m. - 5:10 p.m.    Repeated concurrent sessions - Choose one
     
   

What Can We Offer the Patient with Resistant Hypertension in 2015?
Joel Handler, MD
  
Safe Transition from H2H
Kim Newlin, RN, CNS, NP-C, FPCNA

Surgical Approaches to Obesity: Long Term Impact on CV Risk
John Morton, MD, MPH, FACS, FASMBS

Cardiac Device Update: New Tools and New Indications
Robin Trupp, PhD, ACNP-BC, CHFN, FAHA

     

Saturday, April 11

 8:00 a.m.   Breakfast
     
8:15 a.m. - 8:25 a.m.  

Welcome

     

8:25 a.m. - 9:25 a.m.

 

A Patient-Centered Approach to Lipid Management in the Complicated Patient
Speaker TBD

 

 

 

9:25 a.m. - 10:10 a.m.

 

Women and Stroke: Guidelines for Prevention
Wende Fedder, RN, MBA, FAHA

 

 

 

10:15 a.m. - 11:00 a.m.

 

Menopausal Hormone Therapy and SERMS: Cardiovascular Risks and Benefits
Cynthia Stuenkel, MD, NCMP

 

 

 

11:00 a.m. - 11:45 a.m.

 

Understanding Sex Differences in Pathophysiology = Improved Treatment of Women with CVD
Marcia Stefanick, PhD

 

 

 

11:45 a.m. - 12:30 p.m.

 

Pregnancy Complications are Predictors of Cardiovascular Disease in Women
Ellen Seely, MD

     
12:35 p.m.  

Closing

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program is accredited for 16 contact hours of continuing education, which includes 3 hours of pharmacology. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.

Slides from 2014 Sessions

Access slides from the 2014 PCNA 20th Annual Symposium.


Provider approved by the California Board of Registered Nursing, Provider No. CEP 16268 for 16 Contact Hours.